---
name: I4.3 Management of LSIL (CIN1) or Less Preceded by ASC-H Cytology 2 Year Negative Follow Up - Recommendation 2

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1991-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
- 
  resourceType: DiagnosticReport
  code: LOINC#10524-7 Microscopic observation [Identifier] in Cervix by Cyto stain
  status: final
  conclusionCode:
  - SNOMEDCT#441088002 Atypical squamous cells on cervical Papanicolaou smear cannot exclude high grade squamous intraepithelial lesion (finding)
  effectiveDateTime: 2019-05-01
- 
  $iterate: *HistologyCin1OrNormalTwoYearsAgo
- 
  resourceType: DiagnosticReport
  code: LOINC#21440-3 Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
  status: final
  conclusionCode:
  - SNOMEDCT#787724008 Human papillomavirus deoxyribonucleic acid test negative (finding)
  effectiveDateTime: 2020-05-01
- 
  resourceType: DiagnosticReport
  code: LOINC#21440-3 Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
  status: final
  conclusionCode:
  - SNOMEDCT#787724008 Human papillomavirus deoxyribonucleic acid test negative (finding)
  effectiveDateTime: 2021-05-01
  
results:
  IsIncludedAndNotExcluded: true
  RareAbnormalityRecommendation: 
    action: 'ManagementHistologyI4'
    text: 'Retest with HPV-based testing (i.e., cotesting or primary hrHPV testing) every 3 years after surveillance tests are negative during the 2-year observation period following histologic LSIL (CIN1) or less preceded by ASC-H or HSIL cytology. Proceed with long-term surveillance (i.e., HPV-based testing every 3 years for at least 25 years, even if this is beyond the age of 65 years (BII).'
  WhichRarityMadeTheRecommendation: 3